Medical Device Security: Data Risks for Connected Medical Devices

The transformation of healthcare through connected medical devices has created unprecedented opportunities for patient monitoring, treatment precision, and clinical efficiency. Yet this digital evolution carries substantial cybersecurity implications that extend far beyond traditional IT security concerns. When medical devices connect to networks, exchange data with EHRs, and communicate wirelessly with monitoring systems, they introduce vulnerabilities that can directly impact patient safety and data integrity. Understanding these data risks has become essential for manufacturers, healthcare providers, and regulatory bodies working to secure the future of connected healthcare.

The IEEE Medical Device Cybersecurity Certification Program represents a critical response to these evolving threats, providing manufacturers with standardized frameworks to evaluate and certify device security before deployment. As healthcare organizations increasingly rely on interconnected systems, the need for robust security measures has never been more urgent.

Connected medical devices operate within a complex ecosystem where data flows continuously between devices, networks, and information systems. Research from the National Institutes of Health demonstrates that increased connectivity to existing computer networks has exposed medical devices to cybersecurity vulnerabilities from which they were previously shielded. This exposure creates multiple pathways for potential compromise, affecting not only data confidentiality but also the integrity and availability of critical medical information.

Recent industry analyses indicate that nearly all healthcare organizations operate environments containing Internet of Medical Things (IoMT) devices with known vulnerabilities, including those that have been actively exploited. These vulnerabilities persist despite growing awareness because medical devices often run on legacy operating systems, lack basic security features, and cannot easily accommodate traditional cybersecurity protections without compromising functionality. A significant proportion of connected medical devices operate on unsupported or end-of-life operating systems, creating persistent security gaps that attackers can exploit.

The consequences extend beyond theoretical risk. Healthcare data breaches are among the most costly of any industry, with average incident costs consistently measured in the millions of dollars, according to IBM’s most recent Cost of a Data Breach research. At the same time, hundreds of millions of patient records have been exposed globally through healthcare-related breaches in recent years. $7.42 million per incident, according to IBM’s 2025 research, while over 305 million patient records were exposed in 2024 alone. These breaches compromise protected health information, disrupt clinical workflows, and in some cases, directly threaten patient safety when device functionality becomes compromised.

Medical device data vulnerabilities manifest across three fundamental security dimensions: confidentiality, integrity, and availability. Each dimension presents distinct risks that require targeted mitigation strategies.

Confidentiality breaches occur when unauthorized parties access sensitive patient data transmitted or stored by medical devices. Many connected devices transmit data through insecure web interfaces or use weak authentication protocols, making interception relatively straightforward for determined attackers. Many connected medical devices still rely on weak or default credentials, leaving them vulnerable to exploitation and making them attractive targets for attackers.

Data integrity risks emerge when attackers manipulate information flowing between devices and clinical systems. Unlike simple data theft, integrity attacks can alter diagnostic readings, medication dosing information, or treatment parameters without immediate detection. This manipulation poses direct patient safety risks, as clinicians may make critical decisions based on compromised data. The increased use of wireless connectivity compounds these risks, as radio frequency communications can be intercepted and modified through man-in-the-middle attacks.

Availability concerns arise when cyberattacks or technical failures prevent access to medical devices or their data. Ransomware attacks have become particularly problematic in healthcare settings, with 67% of healthcare organizations experiencing ransomware incidents in 2024. These attacks can disable critical medical equipment, lock healthcare providers out of essential systems, and delay time-sensitive treatments. Reporting and recovery timelines in healthcare are often prolonged, extending the period of operational disruption and patient risk.

Regulatory frameworks have evolved significantly to address medical device cybersecurity challenges. The U.S. Food and Drug Administration’s June 2025 cybersecurity guidance establishes comprehensive requirements for device manufacturers, emphasizing security throughout the product lifecycle rather than treating it as a one-time compliance exercise. This guidance aligns with Section 524B of the Federal Food, Drug, and Cosmetic Act, mandating that manufacturers demonstrate robust cybersecurity measures in premarket submissions.

The FDA now requires manufacturers to include Software Bill of Materials (SBOM) documentation, vulnerability management plans, and evidence of secure development practices in regulatory submissions. These requirements reflect a fundamental shift toward transparency and accountability in medical device security. Manufacturers must demonstrate not only that their devices are secure at the time of approval but also that they have systems in place to identify and address vulnerabilities throughout the device’s operational life.

International standards organizations have developed complementary frameworks to support these regulatory requirements. The IEEE 2621 Series of standards provides specific guidance for connected diabetes devices, with an architecture designed to support extension to additional medical device categories over time. These standards describe security functional requirements, define assurance packages, and establish testing protocols that remove ambiguity from the certification process. The FDA has designated IEEE 2621.2 as a Recognized Consensus Standard, streamlining the regulatory pathway for compliant devices.

The ISO/IEC 80001 series addresses risk management for IT networks incorporating medical devices, while IEC 62304 defines software lifecycle processes for medical device development. Together, these standards create a comprehensive framework for addressing cybersecurity throughout device design, development, deployment, and maintenance phases.

Healthcare organizations face significant challenges implementing effective medical device security programs. Fewer than one in five healthcare security leaders report being extremely confident in their ability to detect and contain attacks on medical devices, even as a large majority report increased investment in medical device and operational technology security over the past year. This confidence gap reflects the complexity of securing diverse device ecosystems that often include legacy equipment, proprietary protocols, and devices that cannot support standard security tools.

Network segmentation has emerged as a critical protective measure, particularly for legacy devices that cannot be easily updated or secured through conventional means. By isolating medical devices on separate network segments with carefully controlled access points, organizations can limit the potential impact of compromised devices. However, this approach must be balanced against the clinical need for data integration and interoperability.

Continuous monitoring and vulnerability management programs enable organizations to identify and address security weaknesses before they can be exploited. Research has shown that a large majority of healthcare organizations have identified IoMT devices with known vulnerabilities and insecure internet connections, highlighting the need for systematic vulnerability assessment and remediation processes. Healthcare organizations must establish clear protocols for patch management, recognizing that medical device patching often requires coordination between manufacturers, biomedical engineering teams, and IT security personnel.

Addressing medical device data risks requires coordinated action across multiple stakeholders. Manufacturers must embed security into device design from the earliest stages, implementing secure coding practices, robust authentication mechanisms, and encrypted communications as standard features rather than afterthoughts. The FDA’s emphasis on secure product development lifecycles reflects this principle, requiring manufacturers to demonstrate systematic approaches to identifying and mitigating security risks.

The expansion of IEEE 2621 certification beyond diabetes devices to encompass broader medical device categories represents an important step in this direction. Through collaborative efforts among manufacturers, healthcare providers, regulators, and standards organizations, the industry can build resilient medical device ecosystems that deliver on the promise of connected healthcare while safeguarding the patients they serve.